Future directions include the experimental validation of the 564 analogues, exploration of multifunctional multi-target peptide-based therapeutics with improved efficacy and clinical utility
Next, the open field test assessed exploratory behavior and provided insights into anxiety-like behavior and general locomotor activity
I wrote a summary on the GLP-1s in January
Keep the pen or vial in its original packaging
The earlier SUSTAIN dose-finding studies for diabetes (Nauck et al., Diabetes Care, 2016) tested multiple dose levels including 0.05 mg, 0.1 mg, 0.2 mg, 0.3 mg, and 0.4 mg daily (note: daily, not weekly) of oral semaglutide and found dose-dependent reductions in HbA1c and body weight at every dose tested
So, weight is not just weight